HuGE Literature Finder
Records
1
-
12
Integrative Methylome and Transcriptome Characterization Identifies SERINC2 as a Tumor-Driven Gene for Papillary Thyroid Carcinoma. Cancers 2023 1 15 (1): . Ying Tianxing, Wang Xumeng, Yao Yunjin, Yuan Jimeng, Chen Shitu, Wen Liping, Chen Zhijian, Wang Xiaofeng, Luo Chi, Sheng Jinghao, Wang Weibin, Teng Liso |
Study of single nucleotide polymorphism of vascular endothelium factor in patients with differentiated thyroid cancer. Clinical diabetes and endocrinology 2022 12 8 (1): 9. Motawea Mohamad Mohsen, Zaki Maysaa El Sayed, Saif Maha, Osman Asmaa Osama Bs, Nada Aml Moham |
Co-Occurrence of Familial Non-Medullary Thyroid Cancer (FNMTC) and Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Associated Tumors-A Cohort Study. Frontiers in endocrinology 2021 7 12 653401. Aswath Kshama, Welch James, Gubbi Sriram, Veeraraghavan Padmasree, Avadhanula Shirisha, Gara Sudheer Kumar, Dikoglu Esra, Merino Maria, Raffeld Mark, Xi Liqiang, Kebebew Electron, Klubo-Gwiezdzinska Joan |
Differences in Mutational Profile between Follicular Thyroid Carcinoma and Follicular Thyroid Adenoma Identified Using Next Generation Sequencing. International journal of molecular sciences 2019 Jun 20 (13): . Borowczyk Martyna, Szczepanek-Parulska Ewelina, D?bicki Szymon, Budny Bart?omiej, Verburg Frederik A, Filipowicz Dorota, Wi?ckowska Barbara, Janicka-Jedy?ska Ma?gorzata, Gil Lidia, Ziemnicka Katarzyna, Rucha?a Mar |
Comparison of diagnostic methods for the detection of a BRAF mutation in papillary thyroid cancer. Oncology letters 2019 4 17 (5): 4661-4666. Zhao Jingzhu, Liu Pengpeng, Yu Yang, Zhi Jingtai, Zheng Xiangqian, Yu Jinpu, Gao Mi |
Effect of MALAT1 Polymorphisms on Papillary Thyroid Cancer in a Chinese Population. Journal of Cancer 2019 10 (23): 5714-5721. Wen Jing, Chen Liang, Tian Hua, Li Ji, Zhang Miao, Cao Qing, Zhang Wei, Chen Shi, Shi Lix |
Global DNA methylation profile in medullary thyroid cancer patients. Experimental and molecular pathology 2018 6 105 (1): 110-114. Ceolin Lucieli, Goularte Ana Paula Palauro, Ferreira Carla Vaz, Romitti Mírian, Maia Ana Lui |
Integrated bioinformatics analysis reveals that the expression of cathepsin S is associated with lymph node metastasis and poor prognosis in papillary thyroid cancer. Oncology reports 2018 5 40 (1): 111-122. Tan Juan, Qian Xiaoxiao, Song Bin, An Xiumin, Cai Tingting, Zuo Zhihua, Ding Dafa, Lu Yibing, Li Ho |
Investigating the association of rs2910164 with cancer predisposition in an Irish cohort. Endocrine connections 2017 Nov 6 (8): 614-624. McVeigh T P, Mulligan R J, McVeigh U M, Owens P W, Miller N, Bell M, Sebag F, Guerin C, Quill D S, Weidhaas J B, Kerin M J, Lowery A |
Investigation of VEGF and IL-8 Gene Polymorphisms in Patients with Differentiated Thyroid Cancer. Clinical laboratory 2016 Dec 62 (12): 2319-2325. Kilic Ilhan, Guldiken Sibel, Sipahi Tammam, Palabiyik Orkide, Akker Mustafa, Celik Ozlem, Soysal-Atile Neslihan, Tuncbilek Nermin, Guven Harun M, Gundogdu A Sadi, Sut Necd |
Anaplastic thyroid cancer: outcome and the mutation/expression profiles of potential targets. Pathology oncology research : POR 2015 Jul 21 (3): 695-701. Wu Hao, Sun Yue, Ye Huihui, Yang Shi, Lee Stephanie L, de las Morenas Anton |
Phase I trial of a combination of the multikinase inhibitor sorafenib and the farnesyltransferase inhibitor tipifarnib in advanced malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research 2009 Nov 15 (22): 7061-8. Hong David S, Sebti Said M, Newman Robert A, Blaskovich Michelle A, Ye Lei, Gagel Robert F, Moulder Stacy, Wheler Jennifer J, Naing Aung, Tannir Nizar M, Ng Chaan S, Sherman Steven I, El Naggar Adel K, Khan Rabia, Trent Jon, Wright John J, Kurzrock Razel |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 30, 2023
- Content source: